Gastrointestinal side effects are the most commonly reported adverse effects of tirzepatide, with clinical trials showing dose-dependent rates: nausea (20-33%), diarrhea (12-23%), vomiting (9-16%), constipation (11-17%), and abdominal pain
The article says weight loss efficacy improves across the dose range, but that the incremental benefit between 1.7 mg and 2.4 mg is modest for some individuals
A common approach is to add a volume of BAC water that makes 1 unit on an insulin syringe equal a nice, round number of micrograms (mcg)
Discuss your specific situation with both your weight loss provider and gynecologist
Microdosing protocols use lower initial concentrations to minimize gastrointestinal side effects while establishing baseline tolerance
doi:10.1016/j.tips.2013.01.001